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a b s t r a c t
Cardiovascular disease trends, complications, and associated therapeutics impact the
dental health and treatment. Such patients require special consideration with regard to
when and which dental treatment is appropriate and what precautions are required.
Alertness to potential oral adverse drug reactions enables referral of patient's to his
physician or cardiologist. Cardiovascular drugs are also known to have mild to potentially
fatal drug interactions. Dental professionals may be the ﬁrst line of defense in the detection
and referral of a patient suspected of having cardiovascular disease, an uncontrolled disease
status, or oral adverse drug reactions, and they have a key role to play in oral and systemic
disease prevention and treatment, in partnership with the patient and his physician.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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Cardiovascular diseases (CVD) comprise of a group of diseases
of the heart and vascular system affecting majority of
individuals worldwide. Ischemic heart disease, Hypertension,
Dysrhythmias, and Infective Endocarditis are some of the
cardiovascular conditions most commonly seen among the
population. Co-existent cardiovascular disease is the most
frequently cited medical condition for patient referral from
general dental practitioners to hospital departments, which
reﬂects widespread concern over potential problems during
treatment. Dentists must be able to identify medical emer-
gencies and adopt the opportune measures to avoid them or
treat them quickly and effectively. A comprehensive treat-
ment plan should be constructed keeping in view all the pros
and cons related to the patient's medical condition.1 Thus, the
present review throws some light on various cardiovascular* Corresponding author.
E-mail addresses: swantikachaudhry@gmail.com (S. Chaudhry), riti
http://dx.doi.org/10.1016/j.ihj.2015.11.034
0019-4832/# 2015 Cardiological Society of India. Published by Elsevieconditions commonly seen in dental practice and a systematic
approach toward their management.
2. Relationship of cardiovascular disease and
periodontitis
Periodontitis has been proposed as having an etiological or
modulating role in cardiovascular and cerebrovascular dis-
ease, diabetes, respiratory disease, and adverse pregnancy
outcome and several mechanisms have been proposed to
explain or support such theories and oral lesions are indicators
of disease progression and oral cavity can be a window to
overall health and body systems. One of these is based around
the potential for the inﬂammatory phenomenon of periodon-
titis to have effects by the systemic dissemination of locally
produced mediators such as C-reactive proteins (CRP),
interleukin-1b (1L-1b) and interleukin-6 (1L-6), and TNF-a.2kajas@gmail.com (R. Jaiswal), drsksperio@gmail.com (S. Sachdeva).
r B.V. All rights reserved.
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explain the association between periodontal disease and heart
disease is that periodontal organisms contain proteins which
cross-react with the heart. The heat-shock protein-60, which is
produced by Tannerella forsythia and Porphyromonas gingi-
valis, has about 60% homology with the mammalian heat-
shock protein. It is known that antibodies to the heat-shock
protein are found in patients with periodontal disease. These
antibodies to heat-shock proteins of periodontal bacteria are
cross-reactive with the heat-shock protein that is exposed in
an injured endothelium or atheromatous plaque. This could
set in motion autoimmune phenomena and contribute to
atheroma formation. There also may be common genetic
mechanisms which provide the link between periodontal
disease and cardiovascular disease.3
3. Prevalence
CVD is the leading cause of death in India, and its contribution
to mortality is rising. It is estimated that approximately 46.9%
patients with CVD in India are affected. According to the
World Health Report of 2002, deaths due to coronary heart
disease (CHD) in India rose from 1.17 million in 1991 to 1.59
million in 2000 and 2.03 million in 2010. In a survey conducted
in 45 rural villages in India, 32% of all deaths were due to CVD.
The mortality from common CVD is about 1.2 million
ischemic heart disease and about 0.8 million stroke cases
every year. Compared with all other countries, India suffers
the highest loss due to deaths from CVD in people aged 35–64
years. The prevalence of CVD is reported to be 2–3 times
higher in the urban population as compared to the rural
population.4
4. Treatment objectives
1) Important goal of treatment to manage patients with
cardiovascular diseases is to deal with all the identiﬁed
risk factors involved.
2) Pre-medication should be considered to alleviate anxiety
and effective analgesia is important to reduce stress.
3) Early and short morning appointments are advised for all
such patients.
4) All the patients are allowed to attain a comfortable position
in a dental chair.
5) Every effort should be made to keep procedure time down to
a minimum, and treatment should be terminated early if
the patient becomes overly anxious.
6) Current medications which the patients are taking and
allergies to any drugs and also any potential drug interac-
tions and side effects are noted.5
5. Dental management of hypertensive
patients
The sequential treatment plan for hypertensive patients
generally starts with consulting the physician regarding thecurrent medical status, medication, and patient management
during periodontal therapy. Dentist must inform the physi-
cian regarding the estimated degree of stress, length of
procedures, and complexity of the individualized treatment
plan.
Following are the stages in management of hypertensive
patients undergoing dental treatment.
Initial evaluation of each patient with hypertension should
include detailed family history of cardiovascular disease,
history of hypertension, medications, duration and antihy-
pertensive treatment history, severity of disease, and its
complications. Before starting dental treatment, dentist has to
assess the presence of hypertension and accordingly the
treatment changes needed. Patients with hypertension are at
increased risk of developing adverse effects in a dental ofﬁce.
Therefore, measuring blood pressure (BP) will be done in the
dental ofﬁce to every new patient for each visit. In patients
with chronic systemic diseases, BP measurement will be
carried out during more complicated dental interventions as
oral surgical procedures, restorative treatment complicated
with longer sessions, placing dental implants, and periodontal
surgery. Routine measurement of BP may reduce the risk of
cardiovascular events and acute complications during dental
treatment, especially when conscious sedation or general
anesthesia is required. Whenever a dentist meets a patient
with hypertensive crisis, the dental procedure should be
postponed and the patient should be immediately sent to a
hospital.6
6. Dental management of angina pectoris
patients
Coronary heart disease is very common in the general
population, and it is therefore likely that a dentist will meet
such a patient in clinical practice. Treatment sequence should
start with taking complete medical history followed by short
morning appointments, premedication with anxiolytics or
prophylactic nitroglycerin, nitrous oxide-oxygen sedation, and
slow delivery of an anesthetic with epinephrine (1:1,00,000)
coupled with aspiration.
Angina pain is often felt in the mandible, with secondary
radiation to the neck and throat. Therefore, the patient may
initially suspect the pain to be of dental origin. The dental
environment increases the likelihood of an angina attack
because of fear, anxiety, and pain. A patient who has an angina
episode in the dental chair should receive the following
emergency dental treatment:
Dental procedure is discontinued and Patient is allowed to
attain a comfortable position. Patient is reassured and
restrictive garments are loosened. Patient is encouraged to
have his own NTG spray 1 or 2 metered sprays depending on
his usual requirement (up to 3 doses of NTG spray can be given
in 15 min). If angina signs and symptoms do not resolve with
this treatment within 2–3 min, administer another dose of
nitroglycerin, monitor the patient's vital signs, call his or her
physician, and be ready to accompany the patient to
emergency department. Oxygen is administered 4–6 lit/min.
Dental procedure may be restarted if it is the usual type
of experience for the patient. If no improvement within
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to the hospital.7
7. Dental management of myocardial
infarction (MI) patients
Although relatively uncommon in the dental settings, cardiac
arrest as a result of MI can occur.
A careful medical history with short appointments along
with anxiety reduction should be carried out. Supplemental
Oxygen via a nasal cannula will help meeting the extra oxygen
requirements of the Myocardium: 4 lit/min. Caution should be
taken if more than 3 ml of 2% Lignocaine Hydrochloride with
1:80,000 adrenaline solution is required. Drug interactions
with potential adverse reactions need to be taken into account
after treatment (e.g. interaction between NSAIDs, Penicillin,
Tetracycline, Metronidazole, and anticoagulants) because
prophylactic antibiotic may need to be considered to prevent
infection. In patients with pacemakers, electrocautery and the
use of cavitron should be avoided. Within 6 months, if any
urgent invasive treatment is required such as Extractions/RCT,
with 6 months of infarction, the treatment should be delivered
in a hospital setting where facilities exist should there be
another attack of MI. After 6 months, myocardial infarction
patients can usually be treated using techniques similar to the
stable angina patient.5
8. Dental management of infective
endocarditis patients
Management of patients with infective endocarditis will
involve Health questioning which will cover history for all
potential categories of risk. If any doubt exists, the patient's
physician should be consulted. Oral hygiene should be
practiced with methods that improve gingival health yet
minimize bacteremia. In patients with signiﬁcant gingival
inﬂammation, oral hygiene is initially limited to gentle
procedures. Oral irrigators are generally not recommended
because their use may induce bacteremia. Susceptible patients
should be encouraged to maintain the highest level of oral
hygiene once soft tissue inﬂammation is controlled.
Severe periodontal disease and areas of periodontal
suppuration or dental focus of infection require elimination.
Pretreatment chlorhexidine mouthrinses are recommended
before all procedures, including periodontal probing, because
they signiﬁcantly reduce the presence of bacteria on mucosal
surfaces. Dental extraction should be avoided in healthy
mouths whenever possible. Endodontic therapy is the
treatment of choice. Also, single extractions are preferable
to multiple extractions. All dental treatment procedures
require antibiotic prophylaxis. When possible, at least 7 days
are kept between appointments (preferably 10–14 days). If
this is not possible, an alternative antibiotic regimen is
selected for appointments within a 7-day time period.
Regular recall appointments, with an emphasis on oral
hygiene reinforcement and maintenance of oral health,
are extremely important for patients with infective endocar-
ditis.89. Dental management of dysrhythmia
patients
A speciﬁc diagnosis of an arrhythmia during a dental
appointment necessitates continuous ECG monitoring and
good knowledge of interpretation of the abnormalities
observed. Thus, in the usual dental setting, patient history,
symptoms, and palpation of the pulse are the available
diagnostic tools. The risk of harmful arrhythmias is also
increased in patients with cardiomyopathies, heart failure,
and valvular problems. Such patients should be carefully
evaluated by their physician and adequate medication and
other measures (such as an implantable cardioverter-deﬁbril-
lator) should be implemented before extensive dental proce-
dures. If a patient with known heart disease develops
arrhythmia during treatment, the treatment should be
discontinued, supplemental oxygen considered, and the
patient status closely monitored. If the patient recovers
quickly, continuation of treatment may be considered if the
patient wishes. Even a brief loss of consciousness, however,
may indicate signiﬁcant cardiac arrhythmia, and the patient
should be referred to medical evaluation. If a patient with
heart disease collapses in the chair, cardiac arrest should be
suspected and emergency medical services activated imme-
diately and cardiopulmonary resuscitation initiated without
delay. These patients are advised to take their medication
regularly. Beta-blockers are the preferred drug of choice.9
10. Dental treatment of patients on
anticoagulant therapy
Patients on anticoagulant therapy should be delicately
handled in a dental setup. This may involve use of local
hemostatic measures to control bleeding in anticoagulated
patients. These include atraumatic surgical technique, ade-
quate wound closure, pressure application, and topical
clotting agents. Oral rinsing with tranexamic acid can also
be used. The indication for anticoagulation should be known
since many indications allow brief discontinuation of antico-
agulant treatment without a substantial increase in the risk of
thrombotic events. On the other hand, anticoagulant treat-
ment should in general not be discontinued in patients with
mechanical valve prostheses. Close collaboration with the
patient's physician is recommended in these matters. In
patients receiving long-term anticoagulant therapy and who
are stably anticoagulated on warfarin, an international
normalized ratio (INR) check 72 h prior to surgery is recom-
mended. This allows sufﬁcient time for dose modiﬁcation if
necessary to ensure a safe INR (2–4) on the day of dental
surgery (including subgingival scaling). There is no need to
check the INR for non-invasive dental procedures.9
11. Conclusion
Patients with a wide variety of cardiovascular diseases are
frequently encountered in dental practice and it is necessary
to treat them. Safe and effective dental management of such
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understanding of the potential hazards during dental treat-
ment, knowledge of drugs used in treatment of cardiovascular
diseases, and the potential adverse effects of drugs commonly
used in periodontal practice. Successful management of such
patients on a Dental Chair is thus based on knowing the patient,
understanding the disease process, and judicious use of
pharmacologic agents designed to produce a state of relaxation,
decrease anxiety, and control the factors which may induce or
contribute to the initiation of these cardiovascular diseases.
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